Immunethep raises additional financing to strengthen strategic industry partnerships and to prepare for clinical trials

Immunethep raises additional financing to strengthen strategic industry partnerships and to prepare for clinical trials

Immunethep, a biotech company that develops anti-bacterial immunotherapies for life-threatening infections, has raised additional funding from its lead investor Portugal Ventures of 0.5+ M€ to further develop strategic industry partnerships and prepare for clinical trials.

Full PR available here